Parameter | Number (%) |
Site |
|
Nasopharynx | 11 (28.2%) |
Oropharynx | 4 (10.3%) |
Hypopharynx | 1 (2.6%) |
Supraglottic larynx | 1 (2.6%) |
Glottic larynx | 4 (10.3%) |
Postcricoid | 6 (15.4%) |
Mandible | 5 (12.8%) |
Maxilla | 3 (7.7%) |
Tongue | 3 (7.7%) |
Sino-nasal | 1 (2.6%) |
Pathological type |
|
Squamous cell carcinoma | 23 (58.9%) |
Adenocarcinoma | 14 (35.9%) |
Mucoepidermoid | 1 (2.6%) |
Adenomucinous | 1 (2.6%) |
Grade |
|
I | 4 (10.3%) |
II | 18 (46.2%) |
III | 7 (17.9%) |
IV | 10 (25.6%) |
T-stage |
|
T1 | 2 (5.1%) |
T2 | 10 (25.6%) |
T3 | 14 (35.9%) |
T4a | 9 (23.1%) |
T4b | 4 (10.3%) |
N-stage |
|
N0 | 11 (28.2%) |
N1 | 8 (20.6%) |
N2 | 10 (25.6%) |
N3 | 10 (25.6%) |
TNM stage |
|
III | 5 (12.8%) |
IVA | 19 (48.7%) |
IVB | 15 (38.5%) |